Holen Sie sich die Stockscreener-App
81.18
1.12%
0.8932
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$80.29
Offen:
$80.76
24-Stunden-Volumen:
93,009
Relative Volume:
0.06
Marktkapitalisierung:
$39.89B
Einnahmen:
$10.19B
Nettoeinkommen (Verlust:
$1.05B
KGV:
38.58
EPS:
2.1044
Netto-Cashflow:
$1.38B
1W Leistung:
+2.77%
1M Leistung:
+1.01%
6M Leistung:
-11.62%
1J Leistung:
-8.73%
1-Tages-Spanne:
$80.76
$81.22
1-Wochen-Bereich:
$78.27
$82.14
52-Wochen-Spanne:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Vergleichen Sie ALC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
81.22 | 39.44B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
ISRG
Intuitive Surgical Inc
|
528.09 | 185.75B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
204.22 | 57.49B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
MDLN
Medline Inc
|
44.93 | 38.28B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
254.03 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-09 | Herabstufung | Stifel | Buy → Hold |
| 2025-12-11 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-08-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Bestätigt | BTIG Research | Buy |
| 2025-03-28 | Bestätigt | Needham | Buy |
| 2025-03-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-01-24 | Bestätigt | Needham | Buy |
| 2025-01-10 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Bestätigt | Needham | Buy |
| 2024-11-12 | Bestätigt | Needham | Buy |
| 2024-10-10 | Hochstufung | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Eingeleitet | Goldman | Buy |
| 2024-03-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Eingeleitet | Bernstein | Outperform |
| 2023-12-18 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Hochstufung | Societe Generale | Sell → Hold |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-08-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-05-12 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-11 | Eingeleitet | BofA Securities | Buy |
| 2022-01-18 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Eingeleitet | Oppenheimer | Perform |
| 2021-07-14 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-06 | Hochstufung | Citigroup | Sell → Neutral |
| 2021-03-22 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-11-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-07-06 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-07-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Argus | Hold → Buy |
| 2020-03-24 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-03-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-26 | Hochstufung | Berenberg | Hold → Buy |
| 2020-01-08 | Eingeleitet | Argus | Hold |
| 2019-10-29 | Eingeleitet | Stephens | Equal-Weight |
| 2019-08-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-06-24 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-06-14 | Eingeleitet | BTIG Research | Neutral |
| 2019-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Alcon Inc Aktie (ALC) Neueste Nachrichten
Berenberg Keeps Alcon at Buy on Expected FY26 Product-supported Growth - marketscreener.com
Is Alcon Inc.'s (VTX:ALC) Recent Stock Performance Influenced By Its Financials In Any Way? - Yahoo! Finance Canada
Aug Action: Is Alcon Inc benefiting from innovation trendsJuly 2025 Movers & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Institution Moves: Is Atmos Energy Corporation currently under institutional pressureJuly 2025 Big Picture & High Accuracy Investment Signals - baoquankhu1.vn
ALC.SW Alcon Inc. (SIX) pre-market: CHF64.68, most active ahead of Feb earnings - Meyka
Alcon completes $750 million share repurchase program By Investing.com - Investing.com Nigeria
Alcon Completes $750 Million Share Repurchase Program - TradingView
ALC.SW Alcon Inc. (SIX) 20 Jan 2026: CHF62.54 close, high volume highlights outlook - Meyka
Alcon completes $750 million share repurchase program - Investing.com
Deutsche Bank Upgrades Alcon to Buy Rating, Boosts PT - marketscreener.com
Portuguese merger review of Alcon-Staar deal ends - MLex
Wet Age-Related Macular Degeneration Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Opthea Limited, Regenxbio, Alkahest, Graybug Vision, Alcon Research, Qilu - Barchart.com
Alcon, Trinidad Eye Hospital bring free eye care to communities - Trinidad and Tobago Newsday
The Truth About Alcon Inc.: Is This ‘Boring’ Eye Company Your Sleeper Money Move? - AD HOC NEWS
Why STAAR Surgical (STAA) Is Down 5.2% After Shareholders Reject Alcon Deal And Board Power Shifts - Yahoo Finance
STAAR CEO exits after company rejects Alcon buyout - MedTech Dive
Contact Lens Market Size to Hit USD 26.64 Billion by 2033, Driven by Rising Vision Care Awareness and Technological Advancements – SNS Insider - GlobeNewswire Inc.
STAAR Surgical (STAA) Board Restructures Amidst Alcon Deal Colla - GuruFocus
Alcon Inc.: How a Surgical Optics Powerhouse Is Quietly Redefining Vision Care - AD HOC NEWS
Stifel reiterates Hold rating on Alcon stock, maintains $80 price target - Investing.com Australia
Stifel reiterates Hold rating on Alcon stock, maintains $80 price target By Investing.com - Investing.com South Africa
Portfolio Recap: What are El Pollo Loco Holdings Inc.’s recent SEC filings showingWeekly Trade Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Market Pulse: Can Alcon Inc stock rebound after recent weaknessTreasury Yields & AI Forecast for Swing Trade Picks - moha.gov.vn
Alcon agrees to acquire LENSAR for $14.00 per share - MSN
Stock Recap: Why Alcon Inc. stock could rally in 2025July 2025 Gainers & Free Community Consensus Stock Picks - Улправда
Staar Surgical asked Alcon to increase merger consideration - MSN
Alcon Streamlines eCOA for Patient-centric Approach - Veeva
Stifel Downgrades Alcon (ALC) and Lowers Target Price to $80.00 - GuruFocus
STAAR Surgical Stock (STAA) Opinions on Failed Alcon Merger - Quiver Quantitative
STAAR Surgical and Alcon terminate proposed merger - Eyes On Eyecare
Intraocular Lens Market Size to Reach USD 9.85 Billion by 2033, Growing at a CAGR of 6.48% - GlobeNewswire Inc.
Stifel downgrades Alcon stock to Hold on UNITY survey concerns - Investing.com
Stifel downgrades Alcon stock to Hold on UNITY survey concerns By Investing.com - Investing.com Nigeria
How sustainable is Alcon Inc. stock dividend payoutJuly 2025 Setups & AI Optimized Trade Strategies - ulpravda.ru
Alcon Inc.'s (VTX:ALC) Intrinsic Value Is Potentially 56% Above Its Share Price - Yahoo Finance
Is Alcon Inc. stock trading at a premium valuationEarnings Summary Report & Scalable Portfolio Growth Methods - ulpravda.ru
Is Alcon Inc. stock a buy on dipsMarket Growth Summary & High Accuracy Swing Entry Alerts - ulpravda.ru
Is Alcon Inc. Ordinary Shares stock supported by strong fundamentalsTrade Exit Summary & Accurate Trade Setup Notifications - ulpravda.ru
Revenue Check: Why Alcon Inc. Ordinary Shares stock could outperform next yearDollar Strength & AI Powered Buy/Sell Recommendations - ulpravda.ru
What Wall Street predicts for Alcon Inc. stock priceTrade Volume Summary & High Conviction Investment Ideas - ulpravda.ru
STAAR Surgical holder Yunqi Capital purchased 750K shares for $21.53 - MSN
Does Alcon Inc. stock trade at a discount to peers2025 Market Outlook & Daily Profit Focused Stock Screening - ulpravda.ru
Alcon Inc. stock: steady vision, selective enthusiasm as investors weigh medical-tech defensiveness - AD HOC NEWS
Can Alcon Inc. stock sustain revenue growth2025 Support & Resistance & Precise Swing Trade Alerts - ulpravda.ru
STAAR Surgical sinks as it plans to terminate sale to Alcon - MSN
Why Alcon Inc. Ordinary Shares stock could outperform next yearJuly 2025 Review & Fast Moving Stock Trade Plans - ulpravda.ru
Alcon Terminates Agreement to Acquire STAAR Surgical, Looks to Product Launches in 2026 - VisionMonday.com
STAAR Surgical vote on Alcon may be delayed againReport - MSN
Finanzdaten der Alcon Inc-Aktie (ALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):